Introduction {#sec1-1}
============

*Staphylococcus intermedius* was first described in 1976 as a coagulase-positive Staphylococcus. It has since been identified as part of normal skin and mucosal flora in a variety of animals, including dogs, cats, pigeons, minks, horses, foxes, raccoons, goats, and gray squirrels.^[@ref1]^ It is the predominant cause of skin and soft tissue infection in dogs,^2-6^ but has only rarely been isolated from humans. However, there are an increasing number of case reports documenting serious invasive infections with *S. intermedius* in humans including infected dog bite wounds,^[@ref4],[@ref7]^ bacteremia,^[@ref1]^ pneumonia, ^[@ref12]^ sinusitis,^[@ref13]^ otitis externa,^[@ref14]^ nail bed infection,^[@ref15]^ mastoiditis,^[@ref16]^ brain abscess,^[@ref17]^ skin abscess,^[@ref18]^ and bacteremia complicated by septic arthritis and iliacus abscess.^[@ref19]^ There has also been one reported outbreak of *S. intermedius* related food intoxication involving over 265 cases in the western United States in 1991.^[@ref20]^ More recently, the discovery of *Staphylococcus pseudintermedius* in 2005 has led to the reclassification of isolates formerly identified as *S. intermedius* based on molecular techniques.^[@ref21]^ The *S. intermedius* group (SIG) was divided *into S. intermedius*, *S. pseudintermedius,* and *Staphylococcus delphini*.^[@ref22]^ According to this new grouping, *S. pseudintermedius,* and not *S. intermedius*, is the species that colonizes and causes infections in dogs and cats, and *S. intermedius* mainly colonizes pigeons.^[@ref22],[@ref23]^ Thus, older reports of *S. intermedius,* particularly in animal bites, are often now viewed as *S. pseudintermedius*.^[@ref24]^

Because human infection with coagulase positive Staphylococci other than *S. aureus* is rare, pitfalls in identification of SIG organisms abound. The true incidence of SIG infections is unknown but likely higher than reported since laboratories tend to presumptively identify coagulase-positive Staphylococci as *S. aureus*.^[@ref1]^ Additionally, *S. intermedius* has been falsely identified as MRSA on the basis of the phenotypic PB2 latex agglutination test which has otherwise good performance for detection of methicillin resistant *S. aureus* and coagulase negative Staphylococci.^[@ref15]^ Talan *et al*. found that 100% of *S. aureus* isolates were coagulase positive at 4 hours compared to only 26% of *S. intermedius* isolates.^[@ref4]^ Thus, microbiology personnel should suspect SIG when coagulase tests proceed more slowly than normal and there is high clinical suspicion, such as history of an animal bite. The presence of SIG can then be confirmed through additional biochemical tests: SIG is pyrrolidonyl arylamidase and β-galactosidase positive in contrast to *S.aureus*.^[@ref4],[@ref25]^ More recently, Sasaki *et al.* found that *S. intermedius* can be chemically distinguished from *S. pseudintermedius* by positive arginine dihydrolase and acid production from beta-gentiobiose and Dmannitol. ^[@ref22]^ The two species can also be distinguished using molecular and genetic testing, as well as MALDI-TOF mass spectrometry, although this is not commonly done.^[@ref24],[@ref26]^

Case Report {#sec1-2}
===========

A 73 year old Caucasian female with a history of severe osteoarthritis developed fever, pain, redness, and swelling of her left elbow one month following a revision left elbow total arthroplasty. The original arthroplasty 10 years earlier had been complicated by infection that was successfully treated with several weeks of intravenous antibiotics according to the patient; the details of this remote infection and treatment were unattainable. She was subsequently well for many years without antibiotics until about 2 years prior to presentation when she began to develop gradually progressive joint instability and pain. She was admitted for elective total arthroplasty of the left elbow. Following surgery, she noted continuous serosanguinous drainage. Her orthopedist aspirated the joint on post-operative day 22. The joint fluid was described as cloudy with 26,000 red blood cells, 1300 white blood cells and 31% neutrophils. No organisms were seen on Gram stain, and bacterial cultures were negative. Patient was not started on antibiotics at this time. A few days later (post-operative day 25) she developed progressive elbow pain and fever and was admitted to the hospital. On admission, her temperature was 102.2°F and her white blood cell count was 11,000 cells/mm^[@ref3]^.

On surgical exploration, a large fluid collection was found in the elbow. The joint capsule appeared intact, however both wound and joint fluid cultures grew *S. intermedius*, as identified by the Vitek II automated microbiology system without further subspeciation. The wound was irrigated but the elbow prosthesis was not removed. Blood cultures were negative. In accordance with CLSI standards, the elbow isolates were determined to be resistant to penicillin and tetracycline but susceptible to oxacillin, erythromycin, clindamycin, chloramphenicol, gentamicin, rifampin, levofloxacin, linezolid, and vancomycin. The patient was treated with intravenous cefazolin and rifampin for six weeks and then transitioned to oral levofloxacin and rifampin with plan for a prolonged course given retention of infected prosthesis. She has not had any recrudescence of disease after 10 months on this regimen and will be reevaluated for possible cessation of therapy at one year's time.

The patient was an avid dog lover. Although she did not recall her dog licking or biting her elbow after surgery, she did report that her dog frequently licked her face. She admitted to frequent close contact with her dog including sharing her bed at night. She denied any recent illness or skin lesions in her dog.

Discussion {#sec1-3}
==========

Human SIG infections are rarely reported. We conducted a literature review by searching PubMed using the terms *Staphylococcus intermedius*, *S. intermedius*, *Staphylococcus delphini, Staphylococcus pseudintermedius*, *infection* and *human*. References cited in these articles were also examined. Only articles published in English were reviewed, and only invasive infections were included in this discussion. The documented outbreak of *S. intermedius* related food-borne illness was excluded as additional clinical information on the individual cases was not available.

We found 17 published articles documenting 29 SIG infections in humans, 25 with *S. intermedius* and 4 with *S. pseudintermedius*. There were no published cases of *S. delphini* in humans. All 29 cases are outlined in [Table 1](#table001){ref-type="table"}, with asterisks marking cases of *S. pseudintermedius*. Notably, *S. intermedius* and *S. pseudintermedius* were initially misidentified as *S. aureus* in 34% of 29 cases. Seven of 29 cases (24%) were reported to be polymicrobial by Gram stain, culture, or PCR restriction fragment length polymorphism. Four of the seven polymicrobial cases occurred in dog bite wounds, and one occurred in a patient with known dog exposure.

*S. intermedius* was first described as a human pathogen in dog bite wounds by Talan in 1989.^[@ref4]^ Overall, 23 of the 29 (79%) of reported cases involved dog bites (11 cases), cat bites (one case), or dog or cat exposure without documented bites (11 cases).^[@ref8],[@ref19],[@ref27]^ The rate of *S. intermedius* infection in dog bite infection case series ranged from two to 21%.^[@ref10],[@ref11]^ Three of the 11 cases in patients without documented bites but with dog or cat exposure were delayed surgical site infections: one case of sinusitis eight months after a transsphenoidal resection of a pituitary adenoma, one case of mastoiditis seven years after a mastoidectomy, and one case of a surgical wound infection five weeks after sinus surgery. ^[@ref13],[@ref16],[@ref27]^ These cases suggest that alteration of local host defenses may be a risk factor for inoculation without a bite.

Six of the 29 cases (21%) in this series occurred in patients without known animal exposures suggesting that humans can carry this organism in the absence of animal pressure. ^[@ref12],[@ref15],[@ref17],[@ref18],[@ref30]^ In one case, an intravenous cocaine user accustomed to licking his syringe prior to injection developed skin abscesses.^[@ref18]^ Notably, screening series have variously found *S. intermedius* in five of 56 (9%) human subjects' oral flora, and five of 17 (29%) subjects' skin flora.^[@ref31],[@ref32]^ Nonetheless, other staphylococcal species are much more common: *S. intermedius* constituted only 23 of 375 staphylococcal isolates from the skin of 17 individuals.^[@ref32]^

Interestingly, regular contact with animals in and of itself does not appear to increase the rate of colonization. Talan *et al*. only found *S. intermedius* in the nasopharyngeal flora of one out of 144 healthy veterinary workers.^[@ref33]^ Similar studies on *S. pseudintermedius* have detected the methicillin-resistant strain of the organism in 3-5% of samples from owners of pets with recent *S. intermedius* clinical infection and seven of 128 (5%) veterinarians.^[@ref34]^ There are data, however, to suggest that transient increases in dogs' bacterial load may increase the risk of transmission to humans. Guardabassi *et al.* found antimicrobial-resistant *S. intermedius* strains in six of 13 dog owners whose pets were being treated for pyoderma. ^[@ref37]^ The owners' strains were mostly identical to those found in their dogs. However, *S. intermedius* was no longer present in these same dog owners two months later, suggesting that human acquisition might be transiently related to increased colonization pressure or antibiotic exposure when their pets are acutely ill.

Only three pet-related cases confirmed matching *S. intermedius* strains between patient and dog via pulse field gel electropheresis and PCR restriction fragment length polymorphism. In two of the cases, the patient reported a history of dog licks at the site of infection. Our patient did not recall any episodes of her dog licking her wound, but transmission could have occurred through direct inoculation of the wound from contact with her dog's skin or indirectly through colonization of the patient followed by invasion of the wound.^[@ref3]^

Treatment of SIG infections in humans has been largely directed by the site of infection and antibiotic susceptibilities. In the cases reviewed, treatment courses ranged from four days of topical antibiotics for otitis externa to eight weeks of intravenous antibiotics for brain abscess.^[@ref14],[@ref17]^ Susceptibility patterns are documented in [Table 2](#table002){ref-type="table"}. Three reports performed testing for the mecA gene, with three of four cases being negative.^[@ref15],[@ref27],[@ref30]^ Guardabassi *et al*. suggest that pets may facilitate the spread of resistance genes, serving as reservoirs, and resistance patterns in human infections may reflect increasing use of antibiotics in pets.^[@ref37]^ In all except one case, patients had complete recovery after treatment: one individual with a *S. intermedius* brain abscess reported minor residual hemiparesis following antibiotic treatment but no recrudescent infection. ^[@ref17]^ Our patient is the first reported case of mechanical prosthesis infection. Despite retention of prosthesis, our patient has been clinically well thus far following six weeks of induction therapy with cefazolin and rifampin followed by 10 months of oral levofloxacin and rifampin to date.

Conclusions {#sec1-4}
===========

To the best of our knowledge, this is the first reported human case of mechanical prosthesis infection with a SIG organism, the second reported case of infection in the immediate post-operative period, and only the fourth case of a SIG post-surgical wound infection. The actual incidence may be higher due to misidentification of *S. intermedius* and *S. pseudintermedius* as *S. aureus*. Immune status does not appear to be a factor in SIG infection, and infections can be monomicrobial or polymicrobial. Overall, infections seem to respond well to therapy guided by susceptibility tests. The possibility of direct transmission of a pathogenic organism from a pet to a postsurgical wound suggests that surgical patients may need to be warned to limit direct contact with pets, particularly dogs, during recovery. However, more studies confirming matching strains between pets and owners are needed to establish direct transmission in the setting of human infection.

###### 

Staphylococcus intermedius group infections in humans.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author, year      Infection site               Age sex   Presentation Pre            disposing factors          Pet exposure          Treatment\*                  Resistance            Sensitivity                      Initially misidentified?   Recovery
  ----------------- ---------------------------- --------- --------------------------- -------------------------- --------------------- ---------------------------- --------------------- -------------------------------- -------------------------- -----------------------
  Atalay, 2005      Brain abscess                4M        Fever, nausea, vomiting,\   None                       Unknown               IV vancomycin x8wks          PCN, MET, CLI, SA     NR                               N                          Partial (minimal\
                                                           headache, lethargic,\                                                                                                                                                                       residual hemiparesis)
                                                           R hemiparesis                                                                                                                                                                               

  Barnham,1992      Hand wound                   78M       Pain, discharge,\           None                       Y (dog bite)          Amoxicillin-clavulanate      PCN, TET              AMC, FUS,\                       N                          Complete
                                                           inflammation                                                                                                                    ERY, FLU, GEN                                               

  Chuang, 2010\*    Catheter-related\            6M        Erythema, catheter site\    Hemophilia B               Y (dog owner)         Oxacillin 100 mg/kg/day\     PCN, COL              VAN, OXA, CIP                    Y(*S. aureus,* then\       Complete
                    bacteremia                             tenderness, fever                                                            xl8d                                                                                *S. intermedius*)          

  Gerstadt, 1999    Pneumonia                    73M       POD5 s/p CABG, fever,\      NIDDM                      N                     Vancomycin                   PCN, OXA, CFZ, CTX\   SXT,GEN,VAN                      N                          Complete
                                                           increased secretions                                                                                      CLI, ERY, OFX                                                                     

  Hatch, 2012       Bacteremia, septic\          76M       Fever, rash                 NIDDM, MDS                 Y (dog owner)         Vancomycin x52d              NR                    VAN                              N                          NR
                    arthritis, iliacus abscess                                                                                                                                                                                                         

  Kelesidis, 2010   Forearm abscesse:            43M       Chills                      HCV intravenous drug use   N                     Amoxicillin-clavulanate\     NR                    OXA, SAM, CFZ,\                  N                          Complete
                                                                                                                                        PO x2wks                                           XCLI,DOX,GEN,SXT,VAN                                        

  Kempker, 2009     Sinusitis                    28F       Foul-smelling\              8 mo s/p transphenoidal\   Y (dog with\          Bilateral\                   CFZ, LVX, OXA,\       NR                               Y (CoNS, then MRSA)        Complete
                                                           nasal discharge,\           resection of pituitary\    recent pyoderma\      sphenoidotomy\               SXT, JET                                                                          
                                                           mild headached              adenoma, CSF leak,\        licked face)          IV vancomycin, then\                                                                                           
                                                                                       diabetes insipidus,\                             PO linezolid to\                                                                                               
                                                                                       anemia                                           complete 6wk course                                                                                            

  Kikuchi, 2004     Mastoiditis                  51F       Irritation, otorrhea        Chronic otitis media\      Y (dog licked ear)    Ofloxacin ear drops          NR                    PCN, OXA,\                       Y *(S. aureus)*            Complete
                                                                                       cholesteatoma,\                                                                                     CFZ, GEN, ERY, CLI,\                                        
                                                                                       7 yrs s/p mastoidectomy                                                                             MIN,VAN,LVX,SXT                                             

  Lee,1994                                       NR        NR                          NR                         Y (dog bite)          NR                           NR                    NR                               N                          NR

                                                 NR        NR                          NR                         Y (dog bite)          NR                           NR                    NR                               N                          NR

                                                 NR        NR                          NR                         Y (dog bite)          NR                           NR                    NR                               N                          NR

                                                 NR        NR                          NR                         Y (dog bite)          NR                           NR                    NR                               N                          NR

                                                 NR        NR                          NR                         Y (dog bite)          NR                           NR                    NR                               N                          NR

                                                 NR        NR                          NR                         Y (dog bite)          NR                           NR                    NR                               N                          NR

                    Leg ulcer                    NR        NR                          Varicose ulcer             Y (dog owner)         NR                           NR                    NR                               N                          NR

                    Leg ulcer                    NR        NR                          Varicose ulcer             Y (dog owner)         NR                           NR                    NR                               N                          NR

                    lnfected suture line         13        NR                          NR                         Y (dog contact)       NR                           NR                    NR                               N                          NR

  Pottumarthy,\     Nail bed infection           60F       Inflamed nail\              Breast cancer\             Unknown               NR                           PCN                   OXA, SAM,\                       Y (MRSA)                   NR
  2004                                                     bed, greenish\              undergoing\                                                                                         AMC, CFZ, CIP, LVX,\                                        
                                                           discoloration               chemotherapy                                                                                        ERY, CLI, GEN, NIT, TET,\                                   
                                                                                                                                                                                           SXT,VAN                                                     

                    Leg laceration               37M       Cellulites, non-healing\    None                       Unknown               NR                           PCN, TET              OXA, SAM, AMC, CFZ,\             Y (MRSA)                   NR
                                                           wound with foul discharge                                                                                                       CIP, LVX, ERY, CLI, GEN, NIT,\                              
                                                                                                                                                                                           SXT,VAN                                                     

  Riegel, 2011\*    ICD-related\                 70F       Purulent drainage, fever    None                       Y (dog exposure)      Cloxacillin 2g\              ERY,AMK               MET, GEN, CIP,\                  Y(*S intermedius*)         Complete
                    endocarditis                                                                                                        Q4hrs 6wks, gentamicin\                            RIF,VAN                                                     
                                                                                                                                        240 mg Qday x5d                                                                                                

  Stegmann,\        Surgical wound               NR,M      Purulent drainage           5wks s/p sinus\            Y (dog, cat, horse\   Fusidic acid gauze\          AMC,CEF,CLI,\         AMK, CHL, FUS,\                  N                          Complete
  2010\*                                                                               surgery for R frontal\     owner)                + 2% mupirocin\              ENR, ERY, GEN,\       LZD, NIT, RIF,\                                             
                                                                                       sinus mucocele, h/o\                             ointment Q1D x3d,\           KAN, MUP, OXA,\       VAN, QDA                                                    
                                                                                       recurrent sinusitis                              topical packing\             PCN, STR, TET,\                                                                   
                                                                                                                                        (0.5 mg/g fluocinonide,\     SXT                                                                               
                                                                                                                                        2.5 mg/g neomycin,\                                                                                            
                                                                                                                                        0.25 mg/g gramicidin,\                                                                                         
                                                                                                                                        100,000 lU/g nystatin) x4d                                                                                     

  Talan, 1989       Hand wound                   45M       Pain, swelling, erythe      None                       Y (dog bite)          Amoxicillin-clavulanate\     PCN                   OXA,SAM,AMC,\                    Y *(S. aureus)*            Complete
                                                                                                                                        500mg PO TID xl0d                                  CFZ,CIRLVX,ERY,\                                            
                                                                                                                                                                                           CLI, GEN, NIT, TET,\                                        
                                                                                                                                                                                           SXT, VAN                                                    

                    Hand, thigh, forearm\        20M       Pain, swelling, erythe      None                       Y (dog bite)          Penicillin V 500 mg\         NR                    PCN                              Y *(S. aureus)*            Complete
                    wounds                                                                                                              POQIDx5d                                                                                                       

                    Forearm wound                34F       Pain, erythema, exud        None                       Y (dog bite)          Penicillin V 250 mg\         NR                    PCN                              Y *(S. aureus)*            Complete
                                                                                                                                        POQIDx5d                                                                                                       

  Talan, 1999       Wound                        INK       NR                          NR                         Y (dog bite)          NR                           NR                    NR                               Y *(S. aureus)*            NR

                    Wound                        NR        NR                          NR                         Y (cat bite)          NR                           NR                    NR                               N                          NR

  Tanner, 2000      Otitis externa               38F       NR                          None                       Y (dog owner)         Topical neomycin,\           NR                    NR                               N                          Complete
                                                                                                                                        polymyxin B                                                                                                    

  Vandenesch,\      Bacteremi                    63M       Inflammation at\            Metastatic NSC lung\       Y (cat owner)         Amoxicillin-clavulanate\     DOX                   PCN, OXA, GEN, KAN,\             N                          Complete
  1995                                                     line site, fever            carcinoma s/p\                                   lgm PO Q8hrs,\                                     CHL ERY, LCM, PRI, RIF,\                                    
                                                                                       splenectomy,\                                    ciprofloxacin 200mg PO\                            SXT,PEF,FOF,VAN,TEC                                         
                                                                                       chemotherapy                                     Q12hrs xl0d                                                                                                    

  Van Hoovels\*     ICD pocket infection         60M       Pocket perforation          Ischemic\                  Unknown               Flucloxacillin 500 mg\       PCN, CLI, ERY         OXA                              Y *(S. aureus)*            NR
                                                                                       cardiomyopathy,\                                 PO QID xlwk                                                                                                    
                                                                                       prostate cancer                                                                                                                                                 

  This report       Elbow wound                  73F       Pain, erythema,\            1 mo s/p revision L\       Y (dog owner)         Cefazolin 2gm IV\            PCN, TET              OXA, ERY,\                       N                          Complete
                                                           swelling, fever             elbow arthroplasty                               Q24hrs, rifampin 300mg\                            CLI, CHL, GEN,\                                             
                                                                                                                                        PO Q12hrsx 4wks                                    RIF, LVX, LZD, VAN                                          
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NR, not reported; PCN, penicillin; MET, methicillin; CLI, clindamycin; SAM, ampicillin sulbactam; AMC, amoxicillin clavulanate; TET, tetracycline; FUS, fusidic acid; ERY, erythromycin; FLU, flucloxacillin; GEN, gentamicin; COL, colistin; OXA, oxacillin; CFZ, cefazolin; CTX, cefotaxime; OFX, ofloxacin; LVX, levofloxacin; DOX, doxycycline; SXT, trimethroprim-sulfamethoxazole; VAN, vancomycin; MIN, minocycline; CIP, ciprofloxacin; NIT, nitrofurantoin; DOX, doxycycline; AMK, amikacin; KAN, kanamycin; LCM, lincomycin; PRI, pristinamycin; PEF, pefloxacin; FOF, fosfomycin; TEC, teicoplanin; CHL, chloramphenicol; RIF, rifampin; LZD, linezolid; CEF, cefalotin; ENR, enrofloxacin; MUP, mupirocin; STR, streptomycin; QDA, quinupristin/daltopristin; MVA, motor vehicle accident; HIV, human immunodeficiency virus; POD, postoperative day; CABG, coronary artery bypass graft; s/p, status post; NIDDM, non-insulin dependent diabetes mellitus; HCV, Hepatitis C virus; MDS, myelodysplastic syndrome; CoNS, coagulase negative Staphylococcus; MRSA, methicillin resistant *Staphylococcus aureus*; NSC, non small cell. \**Staphyloccocus pseudintermedius* infection. °Duration not specified unless otherwise noted. See reference list.

###### 

Antibiotic susceptibilities across cases reviewed.

                                      Isolates tested   Isolates susceptible (%)
  ----------------------------------- ----------------- --------------------------
  Aminoglycosides                     23                18 (78%)
      Amikacin                        1                 0 (0%)
      Erythromycin                    10                7 (70%)
      Gentamicin                      10                10 (100%)
      Kanamycin                       1                 1 (100%)
      Streptomycin                    1                 0 (0%)
  Cephalosporins                      8                 5 (63%)
      Cefazolin                       7                 5 (71%)
      Cefotaxime                      1                 0 (0%)
  Glycopeptides                       12                12 (100%)
      Teicoplanin                     1                 1 (100%)
      Vancomycin                      11                11 (100%)
  Lincosamides                        10                7 (70%)
      Clindamycin                     9                 6 (66%)
      Lincomycin                      1                 1 (100%)
  Penicillins                         35                22 (63%)
      Amoxicillin-clavulanate         4                 4 (100%)
      Ampicillin-sulbactam            5                 4 (80%)
      Flucloxacillin                  1                 1 (100%)
      Methicillin                     2                 1 (50%)
      Oxacillin                       10                8 (80%)
      Penicillin                      13                4 (31%)
  Quinolones                          14                12 (86%)
      Ciprofloxacin                   5                 5 (100%)
      Levofloxacin                    7                 6 (86%)
      Ofloxacin                       1                 0 (0%)
      Pefloxacin                      1                 1 (100%)
  Streptogramins                      2                 1 (50%)
      Pristinamycin                   1                 1 (100%)
      Quinupristin/dalfopristin       1                 0 (0%)
  Tetracyclines                       9                 4 (44%)
      Doxycycline                     2                 1 (50%)
      Minocycline                     1                 1 (100%)
      Tetracycline                    6                 2 (33%)
  Other                                                 
      Chloramphenicol                 2                 2 (100%)
      Colistin                        1                 0 (0%)
      Fosfomycin                      1                 1 (100%)
      Fusidic acid                    1                 1 (100%)
      Linezolid                       1                 1 (100%)
      Mupirocin                       1                 1 (100%)
      Nitrofurantoin                  3                 3 (100%)
      Rifampin                        3                 3 (100%)
      Trimethoprim-sulfamathoxazole   8                 7 (88%)

Method of susceptibility testing was not reported in 11 of 17 articles reviewed. Reported methods included the automated Vitek system, Phoenix automated system, disc diffusion testing, manual dilution testing. Only two published reports referenced CLSI guidelines.
